Alzheimer's Disease & Memory Disorders Center
The Largest Memory Assessment Program in Rhode Island
The TANGO Study
If you would like to find out more, please send your information to the study team online, and the coordinator will contact you. You can also call toll free at 1-844-563-6679, or email firstname.lastname@example.org.
Sponsored by Biogen, TANGO is a multiple dose multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of BIIB092 in subjects with mild cognitive impairment due to Alzheimer’s disease and mild Alzheimer’s disease.
Intended for subjects with a diagnosis of mild cognitive impairment or mild Alzheimer’s disease, the study drug in the TANGO trial is an experimental antibody treatment which targets Tau protein.
People who may be able to take part in this study:
- Are 50 to 85 years old
- Have a diagnosis of mild cognitive impairment or early Alzheimer’s disease
- Have a study partner who can go to some study visits to answer questions about the study participant’s symptoms